|
BCL2L13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.657500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.575500E-02 |
| Normal-vs-Stage2 |
2.800000E-01 |
| Normal-vs-Stage3 |
2.303700E-02 |
| Normal-vs-Stage4 |
3.776200E-01 |
| Stage1-vs-Stage2 |
9.011400E-01 |
| Stage1-vs-Stage3 |
3.014600E-01 |
| Stage1-vs-Stage4 |
8.020600E-01 |
| Stage2-vs-Stage3 |
5.807200E-01 |
| Stage2-vs-Stage4 |
7.835400E-01 |
| Stage3-vs-Stage4 |
3.472800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.830200E-02 |
| Normal-vs-AfricanAmerican |
3.095400E-01 |
| Normal-vs-Asian |
1.802770E-01 |
| Caucasian-vs-AfricanAmerican |
9.290600E-01 |
| Caucasian-vs-Asian |
8.761800E-01 |
| AfricanAmerican-vs-Asian |
9.803400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.949700E-02 |
| Normal-vs-Female |
9.078400E-02 |
| Male-vs-Female |
3.538800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.446400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.630500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.205200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.195000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.118600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.058200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.403000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.833400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.575600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.717400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.664200E-01 |
| Classical-VS-Follicular |
5.077200E-03 |
| Classical-VS-Other |
1.466630E-01 |
| Classical-VS-Normal |
4.044800E-01 |
| Tall-VS-Follicular |
3.421900E-02 |
| Tall-VS-Other |
1.414370E-01 |
| Tall-VS-Normal |
6.034800E-01 |
| Follicular-VS-Other |
8.030000E-01 |
| Follicular-VS-Normal |
2.683700E-03 |
| Other-VS-Normal |
2.034000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.441400E-03 |
| Normal-vs-N1 |
6.585900E-02 |
| N0-vs-N1 |
9.787800E-01 |
|
|
